Paper Review Records
All Paper Review Records
6 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Targeting the TL1A pathway in inflammatory bowel disease: mechanistic insights and emerging therapeutic pipeline
Mohammed Nabil Quraishi; Vipul Jairath; Badr Al-BawardyShow moreShow less
1. Department of Gastroenterology, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates; 2. Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom; 3. College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates; 4. Department of Medicine, Division of Gastroenterology, Western University, London, Ontario, Canada; 5. Alimentiv, Inc, London, Ontario, Canada; 6. London Health Research Institute, London, Ontario, Canada; 7. Department of Epidemiology and Biostatistics, University of Western Ontario, London, Ontario, Canada; 8. Department of Gastroenterology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; 9. Department of Internal Medicine, Section of Digestive Diseases, Yale School of Medicine, New Haven, CT, United States; 10. College of Medicine, Alfaisal University, Riyadh, Saudi ArabiaShow moreShow less
Comments on incidence estimates and rural ascertainment in the Kinta Valley IBD follow-up study
Xiaohe Zhang; Chaochi YueShow moreShow less
1. College of Integrative Chinese and Western Medicine, Southwest Medical University , Luzhou, Sichuan, 646000,; 2. Department of Traditional Chinese Medicine, The Affiliated Hospital of Southwest Medical University , Luzhou, Sichuan, 646000,Show moreShow less
Interpreting oral dysbiosis during nutritional therapy in pediatric Crohn disease
Huan Xu; Tongdong Zeng; Wen WangShow moreShow less
1. Department of Gastroenterology, Chengdu Integrated TCM and Western Medicine Hospital , Chengdu, 610095,; 2. Chengdu University of Traditional Chinese Medicine Department of Gynecology, , Chengdu, 610075,; 3. Department of Laboratory Medicine, The Second Affiliated Hospital of Chengdu Medical College (Nuclear Industry 416 Hospital) , Chengdu, 610066,Show moreShow less
Trained immunity: An unexplored component of IBD pathogenesis
Michael Doulberis; Stergios A Polyzos; Abbas Yadegar; Jannis KountourasShow moreShow less
1. Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich , Zurich, 8091,; 2. Division of Gastroenterology and Hepatology, Medical University Department, Kantonsspital Aarau , Aarau, 5001,; 3. Department of Medicine, Second Medical Clinic, Ippokration Hospital, Aristotle University of Thessaloniki , Thessaloniki, 54642, Macedonia,; 4. First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki , Thessaloniki, 54642, Macedonia,; 5. Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences , Tehran,Show moreShow less
Novel SLC10A2 variants induce primary bile acid malabsorption and dysbiosis with IBD-like features
Casey R Johnson; Lily Gillette; Qurbonali Qurbonov; Abigail Plone; Stefanie S Schmieder; Michael Anderson; Katie Cibelli; Yanjia Jason Zhang; Krishnan Raghunathan; Michael Field; Alka Goyal; Stacy A Kahn; Scott B Snapper; Jocelyn A Silvester; Jay R ThiagarajahShow moreShow less
1. Division of Gastroenterology, Hepatology and Nutrition, Boston Children’s Hospital, Harvard Medical School , Boston, MA,; 2. Center for Microbiome Therapeutics and Informatics, Massachusetts Institute of Technology , Cambridge, MA,; 3. Department of Pediatric Gastroenterology, Hepatology and Nutrition, Stanford University , Stanford, CA,; 4. Harvard Digestive Disease Center, Harvard Medical School , Boston, MA,; 5. Congenital Enteropathy Program, Boston Children’s Hospital , Boston, MA,Show moreShow less
Metabolome remodeling with reverse-engineered exclusive enteral nutrition in children with active Crohn’s disease
David L Suskind; Lucas R Hoffman; Dale Lee; Adrian J Verster; Hengqi Betty Zheng; Kendra Francis; Mason Nuding; Jairam Vanamala; Ghassan Wahbeh; Hayley Purcell; Danijel Djukovic; Daniel Raftery; Hillary S HaydenShow moreShow less
1. Inflammatory Bowel Disease Center, Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Seattle Children’s Hospital , Seattle, WA 98105,; 2. Department of Microbiology, University of Washington , Seattle, WA 98195,; 3. Pythia Informatics , Ottawa, ON K1S 0S7,; 4. Northwest Metabolomics Research Center, Department of Anesthesiology and Pain Medicine, University of Washington , Seattle, WA 98109,Show moreShow less
FAQ
How long does INFLAMMATORY BOWEL DISEASES take to review a manuscript?
As of 2026-11-19, CrushSCI has 6 complete review records for INFLAMMATORY BOWEL DISEASES. The fastest paper went from submission to acceptance in 1 days (Comments on incidence estimates and rural ascertainment in the Kinta Valley IBD follow-up study, received 2026-06-17, accepted 2026-06-18); the slowest took 238 days. The average is 80.7 days and the median is 78.5 days. The fastest record has an unusually short interval; please check the original source.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
